Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Colorcon
Boehringer Ingelheim
McKesson
Moodys

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CODEINE SULFATE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Codeine Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01009697 Dose Linearity Study of Codeine Sulfate Under Fasted Conditions Completed Roxane Laboratories Phase 1 2008-03-01 The objective of this study was to examine the dose linearity of Roxane Laboratories' 15 mg, 30 mg, and 60 mg codeine sulfate tablets under fasted conditions
NCT01009853 Steady State Study of Codeine Sulfate Completed Roxane Laboratories Phase 1 2008-01-01 Study to characterize the steady-state pharmacokinetics of codeine and its metabolites morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G) after oral administration of Roxane Laboratories' codeine sulfate tablets administered at a dose of 15 mg Q4H x 5 days.
NCT01009892 Food Effect Study of Codeine Sulfate Completed Roxane Laboratories Phase 1 2008-01-01 The study was designed to assess the effect of food on the absorption of codeine from Roxane Laboratories' 60 mg Codeine Sulfate tablet
NCT01010139 Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions Completed Roxane Laboratories N/A 2006-08-01 The objective of this study designed to characterize the pharmacokinetics and comparative bioavailability of Roxane Laboratories' codeine sulfate tablets after oral administration of 60 mg doses as 1 x 60 mg, 2 x 30 mg and 4 x 15 mg under fasted conditions.
NCT01010152 Comparative Bioavailability Study of Codeine Sulfate Completed Roxane Laboratories Phase 1 2008-01-01 The objective of this study was to assess the comparative bioavailability of codeine from Roxane Laboratories' Codeine Sulfate 30mg tablets to Tylenol® #3 (acetaminophen 300mg with codeine phosphate 30mg) under fasted conditions
NCT01676493 A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain Terminated Quintiles, Inc. Phase 3 2012-08-01 This is a multicenter, open-label study to evaluate the safety and PK of oral codeine sulfate in pediatric subjects with mild to moderate post-procedural pain.
NCT01676493 A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain Terminated Roxane Laboratories Phase 3 2012-08-01 This is a multicenter, open-label study to evaluate the safety and PK of oral codeine sulfate in pediatric subjects with mild to moderate post-procedural pain.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Codeine Sulfate

Condition Name

Condition Name for Codeine Sulfate
Intervention Trials
Pain 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Codeine Sulfate
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Codeine Sulfate

Trials by Country

Trials by Country for Codeine Sulfate
Location Trials
United States 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Codeine Sulfate
Location Trials
Texas 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Codeine Sulfate

Clinical Trial Phase

Clinical Trial Phase for Codeine Sulfate
Clinical Trial Phase Trials
Phase 3 1
Phase 1 4
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Codeine Sulfate
Clinical Trial Phase Trials
Completed 5
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Codeine Sulfate

Sponsor Name

Sponsor Name for Codeine Sulfate
Sponsor Trials
Roxane Laboratories 6
Quintiles, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Codeine Sulfate
Sponsor Trials
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Harvard Business School
Medtronic
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.